US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Elanco Animal Health Inc

us-stock
To Invest in {{usstockname}}
us-stock
$22.18 -0.0138(-1.38%) ELAN at 04 Dec 2025 04:30 PM Drug Manufacturers - Specialty & Generic
Lowest Today 22.16
Highest Today 22.65
Today’s Open 22.63
Prev. Close 22.49
52 Week High 23.70
52 Week Low 8.02
Day’s Range: Low 22.16 High 22.65
52-Week Range: Low 8.02 High 23.70
1 day return -
1 Week return -4.58
1 month return -1.42
3 month return +26.96
6 month return +64.78
1 year return +81.06
3 year return +72.74
5 year return -24.55
10 year return -

Institutional Holdings

Dodge & Cox 16.69

FMR Inc 13.06

Dodge & Cox Stock I 11.14

PRIMECAP Management Company 10.42

Vanguard Group Inc 9.63

BlackRock Inc 4.64

Dimensional Fund Advisors, Inc. 4.58

Vanguard PRIMECAP Inv 4.10

T. Rowe Price Investment Management,Inc. 3.94

Black Creek Investment Management Inc 3.87

iShares Core S&P Mid-Cap ETF 3.25

Vanguard Total Stock Mkt Idx Inv 3.13

Citadel Advisors Llc 2.76

Vanguard Small Cap Index 2.43

UBS Group AG 2.11

Vanguard Capital Opportunity Inv 2.10

CI Global Leaders Fund D 2.10

Morgan Stanley - Brokerage Accounts 2.01

Strategic Advisers Fidelity US TtlStk 2.01

Shapiro Capital Management Co Inc 1.87

State Street Corp 1.84

Nuveen, LLC 1.66

Fidelity Low-Priced Stock 1.65

Brandes Investment Partners & Co 1.63

Geode Capital Management, LLC 1.62

Vanguard Small Cap Value Index Inv 1.56

Barrow Hanley Mewhinney & Strauss LLC 1.54

Vanguard PRIMECAP Core Inv 1.50

DFA US Small Cap Value I 1.26

Manufacturers Life Insurance Co 1.22

Dodge & Cox Balanced Composite 1.16

Dodge & Cox Balanced I 1.16

Fidelity Series Value Discovery 1.13

ClearBridge Advisors, LLC 1.09

Vanguard Institutional Extnd Mkt Idx Tr 1.07

Fuller & Thaler Asset Management Inc 1.03

T. Rowe Price US Smlr Coms Eq A 0.95

Fidelity VIP Mid Cap Initial 0.88

Dodge & Cox Global Stock I 0.75

T. Rowe Price Small-Cap Stock 0.75

Market Status

Strong Buy: 6

Buy: 1

Hold: 8

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 11174.46 M

PB Ratio 1.7131

PE Ratio 321.2857

Enterprise Value 15081.01 M

Total Assets 12614.00 M

Volume 6481844

Company Financials

Annual Revenue FY24:4439000000 4439.0M, FY23:4367000000 4367.0M, FY22:4418000000 4418.0M, FY21:4765000000 4765.0M, FY20:3273300000 3273.3M

Annual Profit FY24:1909000000 1909.0M, FY23:2504000000 2504.0M, FY22:2505000000 2505.0M, FY21:2631000000 2631.0M, FY20:1606700000 1606.7M

Annual Net worth FY24:338000000 338.0M, FY23:-1144000000 -1144.0M, FY22:-74000000 -74.0M, FY21:-472000000 -472.0M, FY20:-560100000 -560.1M

Quarterly Revenue Q3/2025:1137000000 1137.0M, Q2/2025:1241000000 1241.0M, Q1/2025:1193000000 1193.0M, Q4/2024:1020000000 1020.0M, Q3/2024:1030000000 1030.0M

Quarterly Profit Q3/2025:607000000 607.0M, Q2/2025:577000000 577.0M, Q1/2025:556000000 556.0M, Q4/2024:389000000 389.0M, Q3/2024:405000000 405.0M

Quarterly Net worth Q3/2025:-34000000 -34.0M, Q2/2025:11000000 11.0M, Q1/2025:67000000 67.0M, Q4/2024:-8000000 -8.0M, Q3/2024:364000000 364.0M

Fund house & investment objective

Company Information Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Organisation Drug Manufacturers - Specialty & Generic

Employees 9000

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Jeffrey N. Simmons

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right